股票/基金 实时行情 股吧

简称:东北制药 代码:000597


会计年度:2011-12-31收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
减:内部抵销数-1,372,107,486.00-1,358,073,100.00-14,034,386.00-1.02
其他108,685,853.0087,380,397.0021,305,456.0019.60
医药商业1,293,440,748.001,183,115,405.00110,325,344.008.53
医药制造3,648,899,229.003,005,976,185.00642,923,044.0017.62

会计年度:2011-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
内部抵销数-714,981,700.00-715,137,300.00155,600.00-0.02
其他57,347,200.0049,460,400.007,886,800.0013.75
原料药销售1,051,020,200.00924,089,500.00126,930,700.0012.08
制剂药销售2,112,204,400.001,714,821,500.00397,382,900.0018.81

会计年度:2010-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
医药制造4,031,038,000.003,038,656,100.00----
医药商业1,690,214,000.001,583,704,500.00----
其他114,984,700.00103,628,100.00----
小计5,836,236,700.004,725,988,700.00----
减:内部抵销数1,206,442,600.001,203,420,700.00----
6.合计4,629,794,200.003,522,568,000.00----
减:内部抵销数-1,206,442,600.00-1,203,420,700.003,021,900.00--
其他114,984,700.00103,628,100.0011,356,600.00--
医药商业3,458,123,200.002,805,476,900.00652,646,300.00--
医药制造2,263,128,800.001,816,883,600.00446,245,200.00--

会计年度:2010-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
内部抵销数-589,041,800.00-589,041,800.00----
其他57,763,100.0052,440,800.005,322,300.009.21
原料药销售1,101,910,100.00785,546,500.00316,363,600.0028.71
制剂药销售--2,052,474,200.00415,806,600.0016.85

会计年度:2009-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
产品销售5,119,330,200.003,554,921,900.00----
减:内部抵销数-319,082,900.00-300,312,300.00-18,770,600.00--
其他62,635,400.0054,252,200.00----
原料药销售2,230,708,500.001,297,720,900.00----
制剂药销售2,888,621,800.002,257,201,000.00----

    5/9 转到